• SPX
  • $5,809.86
  • 0.21 %
  • $12.44
  • DJI
  • $42,374.36
  • -0.33 %
  • -$140.59
  • N225
  • $37,913.92
  • -0.6 %
  • -$229.37
  • FTSE
  • $8,269.38
  • 0.13 %
  • $10.74
  • IXIC
  • $18,415.49
  • 0.76 %
  • $138.83

Latest trial over Bayer's Roundup ends with hung jury

By Reuters   |   Mar 1, 2024 at 05:42 PM EST
Latest trial over Bayer's Roundup ends with hung jury

By Brendan Pierson

(Reuters) - The latest trial over claims that Bayer's Roundup weedkiller causes cancer ended with a hung jury on Friday, the company said, highlighting the continued uncertainty surrounding the litigation.

Delaware Superior Court Judge Vivian Medinilla declared a mistrial in a case brought by the family of deceased South Carolina groundskeeper Anthony Cloud, after jurors said they could not agree on a verdict after more than three days of deliberations.

A lawyer for the Cloud family could not immediately be reached for comment. The family can still pursue another trial.

The mistrial came as jurors were deliberating in a similar case in Arkansas.

Around 165,000 claims have been made in the U.S. against Bayer for personal injuries allegedly caused by Roundup, which the company acquired as part of its $63 billion purchase of U.S. agrochemical company Monsanto in 2018.

Most plaintiffs, including Cloud's family and the Arkansas plaintiffs, allege that the product caused a type of cancer called non-Hodgkins lymphoma.

Bayer has said that decades of studies have shown Roundup and its active ingredient, glyphosate, are safe for human use.

Roundup is among the most widely used weedkillers in the United States, though Bayer phased out its sales for home use last year.

Bayer has won 10 of the last 16 Roundup trials, but plaintiffs have scored large verdicts totaling more than $4 billion, including $2.25 billion in a single case in January.

The company is appealing those verdicts, which include large punitive damages awards that are likely to be reduced because they exceed U.S. Supreme Court guidance.

The losses have led some investors to question Bayer's legal strategy in defending the Roundup cases, though the company has so far held firm that it will fight them in court.

In 2020, Bayer settled most of the then-pending Roundup cases for up to $9.6 billion but failed to get a settlement covering future cases. More than 50,000 claims remain pending, and at least 10 additional Roundup trials are expected later this year.

(Reporting By Brendan Pierson in New York, Editing by Alexia Garamfalvi, Bill Berkrot and Rosalba O'Brien)

Did you find this insightful?


We are preparing, please wait

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.